England - London • Industry focus

Slaughter and May

More informationMore information

The broad team at Slaughter and May handles a range of contentious and non-contentious issues, such as patent disputes, the commercialisation of patent portfolios, and mandates -relating to confidential information. Claire Jackson leads the team alongside Duncan Blaikie; Jackson has a great deal of expertise in corporate matters, often advising clients on demergers and joint ventures, while Blaikie primarily handles IP-related issues, including R&D, licensing and collaboration agreements.

Legal 500 Editorial commentary

Key clients

  • GlaxoSmithKline
  • Hikma
  • Thermo Fisher
  • Novo Nordisk
  • Bupa
  • GE Healthcare
  • Union Medical
  • Reckitt Benckiser
  • Immunocore
  • Oxford Nanopore
  • Lonza
  • CSL
  • Enara Bio
  • Artha Health Limited
  • International Finance Facility For Immunisation Company
  • Mylan
  • Illumina
  • Cantel Medical Corp
  • Varian Medical Systems
  • Oxford Sciences Enterprises
  • Bunzl
  • Afreximbank
  • Takeda
  • Virgin Active
  • Deepmind
  • GHO Capital
  • AbbVie
  • Foundation for Innovative New Diagnostics
  • Givaudan
  • Ossur
  • Alexion
  • Royal Flying Doctor Service of Australia
  • St John Ambulance
  • ViiV Healthcare

Work highlights

  • Advised GSK plc on the separation of its Consumer Healthcare business to form Haleon plc.
  • Advised the African Union on all aspects of its program to procure Covid-19 vaccines, over and above the vaccines it is securing through the COVAX Investments Limited facility and other programmes including in respect of all IP issues connected with the procurement.
  • Advised GHO Capital with respect to the acquisition of Sterling Pharma.

Lawyers

Next Generation Partners

Claire Jackson

Slaughter and May

Partner; Claire has a broad corporate and corporate finance practice, advising on all forms of domestic and international M&A transactions, including public takeovers, private acquisitions and disposals, joint ventures, and equity financings. She has particular expertise in the pharmaceutical, life sciences and healthcare and insurance sectors. Claire also has experience in shareholder activism and has advised a number of corporate clients on recent activist campaigns.

Practice head

The lawyer(s) leading their teams.

Claire Jackson, Duncan Blaikie